Kewalramani Reshma sold VRTX
February 20, 2024 · Form 4 insider transaction
Kewalramani Reshma sold 7,019 shares of Vertex Pharmaceuticals Incorporated at $420.58 per share, a transaction worth $2.95M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,019
Price
$420.58
Total value
$2.95M
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 20, 2024
Filing dateFebruary 21, 2024
Shares owned after145,893
OwnershipDirect
10b5-1 planNo
AmendedNo